Regarding FasL in lacrimal glands from individuals with SS, it was reported that a down-regulation of FasL was closely associated with an enlargement of lacrimal glands in SS [48], and that the down-regulation of FasL in SS patients with enlarged lacrimal glands was induced by a point mutation of FasL gene promoter. Here, FASLG is linked to synovial sarcoma.